New patent expiration for APGDI drug MYRBETRIQBy DrugPatentWatch – Make Better Decisions / May 4, 2024 Annual Drug Patent Expirations for MYRBETRIQ Myrbetriq is a drug marketed by Apgdi and is included in two NDAs. It is available from three suppliers. There are eight patents protecting…Source